BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17065619)

  • 1. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Kao LM; Bush K; Barnewall R; Estep J; Thalacker FW; Olson PH; Drusano GL; Minton N; Chien S; Hemeryck A; Kelley MF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3535-42. PubMed ID: 17065619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exposure therapy of inhalational anthrax in the common marmoset.
    Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
    Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
    Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children.
    Li F; Nandy P; Chien S; Noel GJ; Tornoe CW
    Antimicrob Agents Chemother; 2010 Jan; 54(1):375-9. PubMed ID: 19858256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Heine HS; Bassett J; Miller L; Bassett A; Ivins BE; Lehoux D; Arhin FF; Parr TR; Moeck G
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3350-7. PubMed ID: 18606841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics.
    Vietri NJ; Purcell BK; Tobery SA; Rasmussen SL; Leffel EK; Twenhafel NA; Ivins BE; Kellogg MD; Webster WM; Wright ME; Friedlander AM
    J Infect Dis; 2009 Feb; 199(3):336-41. PubMed ID: 19099484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.
    Vietri NJ; Purcell BK; Lawler JV; Leffel EK; Rico P; Gamble CS; Twenhafel NA; Ivins BE; Heine HS; Sheeler R; Wright ME; Friedlander AM
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7813-6. PubMed ID: 16672361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis).
    Vasconcelos D; Barnewall R; Babin M; Hunt R; Estep J; Nielsen C; Carnes R; Carney J
    Lab Invest; 2003 Aug; 83(8):1201-9. PubMed ID: 12920249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
    Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
    Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.
    Meyerhoff A; Albrecht R; Meyer JM; Dionne P; Higgins K; Murphy D
    Clin Infect Dis; 2004 Aug; 39(3):303-8. PubMed ID: 15306995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
    Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS
    Antimicrob Agents Chemother; 2010 May; 54(5):1678-83. PubMed ID: 20145081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis.
    Kihira T; Sato J; Shibata T
    J Infect Chemother; 2004 Apr; 10(2):97-100. PubMed ID: 15160302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
    Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP
    Antimicrob Agents Chemother; 2010 Mar; 54(3):991-6. PubMed ID: 20047912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa.
    Deguchi T; Seike K; Yasuda M; Matsumoto T
    J Infect Chemother; 2011 Oct; 17(5):726-30. PubMed ID: 21409530
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus).
    Nelson M; Lever MS; Dean RE; Pearce PC; Stevens DJ; Simpson AJ
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3922-6. PubMed ID: 20625157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.